Back to AI News
arxiv

RECITE: Revising Eligibility Criteria Incorporating Textual Evidence

RECITE is a framework that automatically discovers and extracts evidence-based revisions for clinical trial eligibility criteria using protocol amendment documents from ClinicalTrials.gov. It constructs a dataset of 11,913 curated instances across 5,735 trials and benchmarks 15 LLM configurations, with the best open-weight model (Gemma 2 9B) and closed-weight model (GPT-4o) achieving normalized scores around 0.74. The framework also uses an agentic literature discovery system to identify 44 paper–trial matches, demonstrating that existing clinical knowledge can be operationalized into actionable trial design recommendations.

AI Brief

Provides a concrete, data-driven method to address enrollment failures in clinical trials by leveraging LLMs and evidence-based criteria revision, with rigorous validation against domain experts.

arXiv:2610.41368v1 Announce Type: new Abstract: Overly restrictive eligibility criteria contribute to widespread enrollment failure in clinical trials, yet published recommendations for how specific criteria should be broadened remain disconnected from trial design at scale. We introduce RECITE (Revising Eligibility Criteria Incorporating Textual Evidence), a framework for automated discovery, extraction, and implementation of evidence-based eligibility criteria revisions. RECITE uses protocol amendment documents from ClinicalTrials.gov to construct a dataset of 11,913 curated instances across 5,735 trials, each pairing original criteria with documentary evidence and target revisions. We benchmark fifteen LLM configurations under truncated-to-context-window and retrieval-augmented generation conditions, on a 3,116-instance sample under an LLM-as-judge protocol validated against ten domain experts (judge vs. human quadratic-weighted Cohen's $\kappa_{qw} = 0.694 \pm 0.096$). The best open-weight model, Gemma 2 9B, achieves $\kappa_{qw}$-aligned ordinal score $3.0 \pm 0.9$ on a 0--4 scale (normalized 0.742) and the best closed-weight model, GPT-4o, reaches $3.0 \pm 0.8$ (normalized 0.745). Using an agentic literature discovery system, we then identified 44 paper--trial matches across five publications providing trial-design and EC-modification evidence. Our findings suggest that existing clinical knowledge can be operationalized into actionable trial design recommendations.
Be the first to rate this article.

Comments & Questions (0)

Captcha
Please be respectful — let's keep the conversation friendly.

No comments yet

Be the first to comment!